Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib for UV-induced Erythema
NCT02090933Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Mar 2004
- Primary completion
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of celecoxib oral solution in sunburn, sponsored by National Cancer Institute. Primary endpoint: Changes in the erythema response at Day 11. Started Mar 2004; status: completed.
02
Drugs
celecoxib oral solution
03
Conditions
sunburn
Beyond the preview
Go deeper on NCT02090933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02090933.